Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | HB0036 |
Trade Name | |
Synonyms | HB-0036|HB 0036 |
Drug Descriptions |
HB0036 is a bispecific antibody that targets T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT) and PD-L1 (CD274), resulting in inhibition of downstream signaling and potentially leading to increased antitumor immune response (NCI Drug Dictionary). |
DrugClasses | PD-L1/PD-1 antibody 117 TIGIT Antibody 19 |
CAS Registry Number | NA |
NCIT ID | C188244 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HB0036 | HB0036 | 0 | 1 |